title: Rebuttal: Do you approve of spending $300 million on HPV vaccination? No.
authors.affiliation: McGill University, 1020 Pine Ave W, Montreal, QC, Canada. abby.lippman@mcgill.ca
authors.forename: Abby
authors.initials: A
authors.lastname: Lippman
authors.forename: Madeline
authors.initials: M
authors.lastname: Boscoe
authors.forename: Carol
authors.initials: C
authors.lastname: Scurfield
mesh_terms: D005260:Female; D006801:Humans; D008389:Marketing of Health Services; D032541:Mass Vaccination; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics*; D012075:Remission, Spontaneous; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology; D016387:Women's Health
chemical_list: D053918:Papillomavirus Vaccines